ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1874

Differences Between Men and Women in the Patient Pathways to Diagnosis of Ankylosing Spondylitis

Mark Hwang1, Martin Rozycki2, Theresa Arndt2, Esther Yi3 and Michael Weisman4, 1McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 2HVH Precision Analytics, LLC, Wayne, PA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

Meeting: ACR Convergence 2020

Keywords: Administrative Data, Ankylosing spondylitis (AS), Cohort Study, education, medical, longitudinal studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Healthcare claims databases can be used to identify patients with ankylosing spondylitis (AS) prior to diagnosis. This study explores differences in pathways to AS diagnosis between men and women by examining the coding of health events over the 2 years prior to AS diagnosis.

Methods: This retrospective cohort study collected administrative claims data from patients in the Truven Health MarketScan® Commercial and Medicare Supplemental Databases from January 2006 to April 2019. The AS population included all patients aged ≥ 18 years with ≥ 2 diagnoses of AS (ICD-9-CM/ICD-10-CM) ≥ 30 days apart who had ≥ 2 years of continuous enrollment prior to first AS diagnosis. Male patients with AS were matched 1:1 to female patients with AS by age, date of AS diagnosis, insurance type, and enrollment duration. Diagnosis codes and physician types were examined over the 2 years prior to AS diagnosis and stratified by men vs women. A set of 1906 AS-related codes in men and women was examined using univariate χ2 tests.

Results: A total of 7744 patients met the inclusion criteria for diagnosis of AS. The mean (SD) age for men and women, respectively, was 45.1 (14.4) and 45.3 (14.1) years; women were less likely than men to be working full time (41.2% vs 47.1%) (Table 1). Of 1906 codes examined for differences between men and women, 281 codes showed significant differences, some of which are highlighted in Tables 2 and 3. In general, women had more overall coding than men across diagnoses and providers. The greatest difference between men and women in categorized disease features was observed for peripheral symptom coding (57.7% of women vs 43.9% of men) (Table 2). Compared with men, women also showed much greater levels of other MSK coding (52.8% vs 40.0%), unspecified coding (59.6% vs 46.9%, and depression (21.2% vs 9.8%). Only gout was significantly more common in men vs women (6.5% vs 2.2%). These differences were observed throughout the 2 years prior to AS diagnosis. However, coding for backache gradually increased in men starting at 12 months before AS diagnosis, whereas axial and sacroiliitis coding increased sharply in men immediately before AS diagnosis, suggesting differences between men and women in pathways to AS or in presentation of disease. When looking at physician types visited in the 2 years prior to AS diagnosis, the greatest difference was observed for rheumatologists (64.2% of women vs 45.1% of men; difference = 19.1%) (Table 3).

Conclusion: This analysis revealed differences between men and women in the time leading up to diagnosis of AS, with the greatest variations observed for peripheral vs axial coding, unspecified coding, MSK symptoms, and depression. These findings, over a range of codes, are consistent with differences in disease phenotype between men and women that result in divergent pathways to diagnosis of AS. Women showed greater levels of coding regardless of the code being examined. A greater number of visits to community rheumatologists for women vs men support the hypothesis that there is a greater challenge in diagnosing the AS disease spectrum in women vs men by clinicians, which merits further investigation. These differences potentially contribute to a delayed, burdened journey to diagnosis of AS in women compared to men.


Disclosure: M. Hwang, Novartis, 5, University of Texas Health Science Center at Houston (UTHealth) Center of Clinical and Translational Sciences KL2 program, 2; M. Rozycki, HVH Precision Analytics, 3; T. Arndt, HVH Precision Analytics, 3; E. Yi, Novartis Pharmaceuticals Corporation, 3; M. Weisman, Novartis, 5, GSK, 5, UCB, 5, Lilly, 5.

To cite this abstract in AMA style:

Hwang M, Rozycki M, Arndt T, Yi E, Weisman M. Differences Between Men and Women in the Patient Pathways to Diagnosis of Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/differences-between-men-and-women-in-the-patient-pathways-to-diagnosis-of-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differences-between-men-and-women-in-the-patient-pathways-to-diagnosis-of-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology